miR-152 inhibited the proliferation, migration, or invasion by targeting the DNMT1 3′UTR directly in hepatitis B virus-related hepatocellular carcinoma [28], ovarian cancer [29], glioma [30], nasopharyngeal cancer [31] and bladder cancer cells [32]. This evidence concerns the gene DNMT1 and ovarian cancer.